Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aerovate Therapeutics, Inc. - Common Stock (NQ: AVTE ) 2.625 +0.025 (+0.96%) Streaming Delayed Price Updated: 9:47 AM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Aerovate Therapeutics, Inc. - Common Stock < Previous 1 2 3 4 5 Next > SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, PFIE, EMKR on Behalf of Shareholders December 06, 2024 From Halper Sadeh LLC Via GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, AVTE, GATO on Behalf of Shareholders December 04, 2024 From Halper Sadeh LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Gatos Silver, Inc. (NYSE - GATO), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. (Nasdaq - AVTE) December 04, 2024 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. November 26, 2024 From Brodsky & Smith LLC Via GlobeNewswire AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE November 04, 2024 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. (Nasdaq - AVTE), Outbrain Inc. (Nasdaq - OB) November 04, 2024 From Brodsky & Smith LLC Via GlobeNewswire “The Future is Bright: Peraso Inc. (NASDAQ: PRSO) Expands Technology for Tactical Applications in High-Demand Industries – More Stocks Inside…” October 31, 2024 Via AB Newswire 12 Health Care Stocks Moving In Thursday's Intraday Session October 31, 2024 Via Benzinga AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders October 31, 2024 From Halper Sadeh LLC Via Business Wire Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders October 31, 2024 From Ademi LLP Via Business Wire 12 Health Care Stocks Moving In Thursday's Pre-Market Session October 31, 2024 Via Benzinga Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement October 31, 2024 From Jade Biosciences Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session October 01, 2024 Via Benzinga AVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q2 2024 August 12, 2024 AVTE stock results show that Aerovate Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Aerovate Therapeutics to Explore Strategic Alternatives July 08, 2024 From Aerovate Therapeutics, Inc. Via GlobeNewswire The 3 Hottest Stock Downgrades From Last Week June 27, 2024 Explore the experts' latest surprising stock downgrades amid significant market shifts and analyst adjustments. Via InvestorPlace Nasdaq Surges Over 200 Points; Aaron's Shares Jump June 17, 2024 Via Benzinga Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 17, 2024 Via Benzinga Crude Oil Rises 1%; Mustang Bio Shares Spike Higher June 17, 2024 Via Benzinga Exposures Fossil Fuels Why 90% Of Aerovate Therapeutics' Value Just Went Up In Smoke June 17, 2024 The company was working on a treatment for pulmonary arterial hypertension, a form of high blood pressure in the lungs. Via Investor's Business Daily Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday? June 17, 2024 Aerovate Therapeutics shares dropped 90.4% following the release of Phase 2b trial results for AV-101 for pulmonary arterial hypertension. Despite being well tolerated, AV-101 failed to meet primary... Via Benzinga US Stocks Mixed; Dow Tumbles Over 100 Points June 17, 2024 Via Benzinga Topics Stocks Exposures US Equities Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension June 17, 2024 AV-101 did not meet the primary endpoint of change in pulmonary vascular resistance (PVR) for any of the studied doses From Aerovate Therapeutics, Inc. Via GlobeNewswire Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference May 21, 2024 From Aerovate Therapeutics, Inc. Via GlobeNewswire AVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q1 2024 May 13, 2024 AVTE stock results show that Aerovate Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights May 13, 2024 From Aerovate Therapeutics, Inc. Via GlobeNewswire Ermenegildo Zegna Reports FY23 Results, Joins Altice USA, Herbalife And Other Big Stocks Moving Lower On Friday April 05, 2024 U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Friday. Shares of Ermenegildo Zegna N.V. (NYSE: ZGN) fell sharply during Friday’s session as the company reported FY23... Via Benzinga Topics Stocks Exposures US Equities Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference March 27, 2024 From Aerovate Therapeutics, Inc. Via GlobeNewswire AVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q4 2023 March 25, 2024 AVTE stock results show that Aerovate Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace < Previous 1 2 3 4 5 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
